March 31 (Reuters) - Valeant Pharmaceuticals (NYSE:VRX) International
Inc's VRX.TO directors and key officers have received a
cease-trade order by the securities regulator in the Canadian
province of Quebec, on the company's request, Valeant said on
Thursday.
In a separate statement, the Autorité Des Marches
Financiers said the order takes effect Thursday and is in place
for 15 days.